Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.
Publication
, Journal Article
Wallace, A; Darcy, K; Alvarez-Secord, A; Hutson, A; Tritchler, D; Kirchgraber, L; Grace, L; Whitaker, R; Berchuck, A; Havrilesky, L
Published in: Gynecologic Oncology
March 2012
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
March 2012
Volume
125
Start / End Page
S37 / S37
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Wallace, A., Darcy, K., Alvarez-Secord, A., Hutson, A., Tritchler, D., Kirchgraber, L., … Havrilesky, L. (2012). Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study. Gynecologic Oncology, 125, S37–S37. https://doi.org/10.1016/j.ygyno.2011.12.084
Wallace, A., K. Darcy, A. Alvarez-Secord, A. Hutson, D. Tritchler, L. Kirchgraber, L. Grace, R. Whitaker, A. Berchuck, and L. Havrilesky. “Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.” Gynecologic Oncology 125 (March 2012): S37–S37. https://doi.org/10.1016/j.ygyno.2011.12.084.
Wallace A, Darcy K, Alvarez-Secord A, Hutson A, Tritchler D, Kirchgraber L, et al. Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study. Gynecologic Oncology. 2012 Mar;125:S37–S37.
Wallace, A., et al. “Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.” Gynecologic Oncology, vol. 125, Elsevier BV, Mar. 2012, pp. S37–S37. Crossref, doi:10.1016/j.ygyno.2011.12.084.
Wallace A, Darcy K, Alvarez-Secord A, Hutson A, Tritchler D, Kirchgraber L, Grace L, Whitaker R, Berchuck A, Havrilesky L. Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study. Gynecologic Oncology. Elsevier BV; 2012 Mar;125:S37–S37.
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
March 2012
Volume
125
Start / End Page
S37 / S37
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis